Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 8;10(12):2433.
doi: 10.3390/microorganisms10122433.

Prebiotic Functions of Konjac Root Powder in Chocolate Milk Enriched with Free and Encapsulated Lactic Acid Bacteria

Affiliations

Prebiotic Functions of Konjac Root Powder in Chocolate Milk Enriched with Free and Encapsulated Lactic Acid Bacteria

Said Ajlouni et al. Microorganisms. .

Abstract

This study investigated the prebiotic functions of Konjac root powder (KRP) when added to chocolate milk (ChM) enriched with 2% of free or microencapsulated lactic acid bacteria (FLAB or ELAB). The effects of different concentrations of KRP (0%, 2% and 4%) and refrigerated storage time on the physical, chemical and microbiological characteristics of this chocolate milk were examined. The results show that pH significantly declined (p < 0.05), while titratable acidity increased in all ChM samples with KRP and FLAB or ELAB during refrigerated storage. The pH values ranged from 6.0 ± 0.03 in samples enriched ELAB and 4% KRP to 6.33 ± 0.03 in ChM enriched with FLAB and 2% KRP. Viscosity of ChM was affected mainly by the added amounts of KRP and storage time. The largest viscosity (5500 cP) was observed in all samples containing 4% KPR on day zero and decreased significantly (p < 0.05) over storage time to reach 2800 cP in ChM samples containing 0% LAB and 4% KRP after 21 days of storage. Changes in LAB counts proved the initial hypothesis that KRP could act as prebiotics in the presence of LAB using chocolate milk as a carrier. The initial LAB counts in inoculated samples on day zero of refrigeration storage were not significantly different (p > 0.05) among all treatments. However, ChM enriched with 2% and 4% KRP and ELAB revealed significantly (p < 0.05) larger LAB counts (4.91 ± 0.78 and 5.0 ± 0.57 log CFU/mL, respectively) than the control (3.85 ± 0.55 log CFU/mL) after 21 days of storage.

Keywords: chocolate milk; konjac root powder; prebiotic; probiotics.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The impact of storage time on the pH of chocolate milk enriched with 0% or 2% LAB and various concentration (0%, 2%, and 4%) of KRP. Columns within each day of measurement with different superscript letters are significantly different (95% confidence level).
Figure 2
Figure 2
The impact of various concentration of KRP on the Viscosity (cP) of chocolate milk that contains 0% LAB, 2% ELAB and 2% FLAB, during the 0, 7, 14 and 21 days of storage. Standard deviation (SD) is presented in the forms of error bars. Columns with different superscript letters are significantly different (95% confidence level) within each group).

Similar articles

References

    1. Turkmen N., Akal C., Ozer B. Probiotic dairy-based beverages: A review. J. Funct. Foods. 2019;53:62–75. doi: 10.1016/j.jff.2018.12.004. - DOI
    1. Brown A.C., Valiere A. Probiotics and medical nutrition therapy. Nutr. Clin. Care. 2004;7:56–68. - PMC - PubMed
    1. Hill C., Guarner F., Reid G., Gibson G.R., Merenstein D.J., Pot B., Morelli L., Canani R.B., Flint H.J., Salminen S., et al. Expert Consensus Document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 2014;11:506. doi: 10.1038/nrgastro.2014.66. - DOI - PubMed
    1. Charles V., Fang Y., Brent D.P. Mechanisms of probiotic action: Implications for therapeutic applications in inflammatory bowel diseases. Inflamm. Bowel Dis. 2008;14:1585–1596. - PubMed
    1. Girardin M., Seidman E.G. Indications for the use of probiotics in gastrointestinal diseases. Dig. Dis. 2011;29:574–587. doi: 10.1159/000332980. - DOI - PubMed

LinkOut - more resources